Last reviewed · How we verify
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management
The purpose of this study is to determine if taking insulin glargine twice a day instead of once a day will better manage pregestational diabetes in pregnant patients. Participants in this study will be randomly assigned to one of two groups: a group that takes insulin glargine once a day, and a group that takes it twice. Continuous glucose monitoring will be used to track blood sugar levels. The main question the study aims to answer is: Will using insulin glargine twice a day instead of once lead to a better glucose time in range?
Details
| Lead sponsor | Eastern Virginia Medical School |
|---|---|
| Phase | PHASE4 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 200 |
| Start date | Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Dec 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pregestational Diabetes
- Pregnancy
Interventions
- Use of insulin glargine once daily
- Use of insulin glargine twice daily
Countries
United States